namely constipation (14.6% and 11.8% for semaglutide 0.5 and 1.0 mg, respectively, vs 3.9% with sitagliptin), nausea (10.7% and 12.7%, vs none with sitagliptin) and diarrhoea (6.8% and 8.8%, vs 1.9% with sitagliptin
Most patients can lose 1-2 pounds each week
Walking, cycling, and swimming help the body use glucose better
Klinic streamlines the process, reducing financial barriers and ensuring your treatment is as seamless as possible
Staying hydrated, avoiding sudden head movements, and practicing balance exercises may help reduce vertigo symptoms
Injection Technique (Subcutaneous) Clean hands and preparation surface Disinfect vial stopper and injection area Draw correct dose into insulin syringe Inject into abdomen, thigh, or upper arm subcutaneous tissue Insert needle at 4590 angle Inject slowly and rotate sites regularly Medical Disclaimer The information provided on this page is intended for research and educational purposes only